Anzeige
Mehr »
Lynx Broker
Login
Samstag, 21.09.2019 Börsentäglich über 12.000 News von 610 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ALP6 ISIN: US1850631045 Ticker-Symbol: CLM 
Stuttgart
20.09.19
16:44 Uhr
0,654 Euro
+0,016
+2,46 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CLEARSIDE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
CLEARSIDE BIOMEDICAL INC 5-Tage-Chart

Aktuelle News zur CLEARSIDE BIOMEDICAL Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoClearside Biomedical, Inc.: Clearside Biomedical Featured at Multiple European Scientific Retinal Congresses3
05.09.Clearside Biomedical, Regenxbio ink sales deal for gene therapy microinjector6
04.09.Clearside Biomedical Shares Rebound On Microinjector Licensing Deal With Regenxbio11
CLEARSIDE BIOMEDICAL Aktien jetzt im kostenlosen Demokonto handeln!
04.09.Clearside Biomedical, Inc. - 8-K, Current Report4
23.08.Clearside Biomedical predicts its uveitis drug will be rejected, after FDA requests more data11
22.08.Mid-Afternoon Market Update: BJ's Wholesale Club Surges Following Upbeat Q2 Earnings; Clearside Biomedical Shares Slide4
22.08.Clearside Stock Plummets After Company Hints At Complete Response Letter For Macular Edema Drug11
22.08.FDA wants more on new manufacturing process from Clearside Biomedical6
22.08.Clearside Bio not quite there with U.S. Xipere application; shares down 48% premarket20
22.08.Clearside Biomedical, Inc. - 8-K, Current Report6
08.08.Clearside up 17% on plan to out-license Xipere17
08.08.Clearside Biomedical's (CLSD) CEO George Lasezkay on Q2 2019 Results - Earnings Call Transcript19
07.08.Clearside Biomedical EPS beats by $0.25, beats on revenue9
06.08.Clearside Biomedical, Inc.: Clearside Biomedical to Present at the 2019 Wedbush PacGrow Healthcare Conference2
31.07.Clearside Biomedical, Inc.: Clearside Biomedical to Report Second Quarter 2019 Financial Results and Provide Corporate ...7
31.07.Clearside Biomedical, Inc.: Clearside Biomedical Announces Multiple Oral Presentations Delivered at the American ...4
18.07.Clearside Biomedical, Inc.: Clearside Biomedical Announces Multiple Oral Presentations to be Given at the American ...6
09.07.Clearside Biomedical licenses microinjector to Aura Biosciences5
20.06.Clearside Biomedical, Inc. - 8-K, Current Report2
11.06.Clearside Biomedical, Inc.: Clearside Biomedical to Present at the JMP Securities Life Sciences Conference5
Seite:  Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2